In this report
High Risk for Invasive Meningococcal Disease Among Patients Receiving Eculizumab (Soliris) Despite Receipt of Meningococcal Vaccine
Lucy A. McNamara, PhD; Nadav Topaz, MSc; Xin Wang, PhD; et al.
Sixteen cases of meningococcal disease were identified in eculizumab recipients in the United States for the period 2008–2016.
Lucy A. McNamara, PhD; Nadav Topaz, MSc; Xin Wang, PhD; et al.
Sixteen cases of meningococcal disease were identified in eculizumab recipients in the United States for the period 2008–2016.
.png)
No hay comentarios:
Publicar un comentario